Recently active
Unread page 10
On the live site this tab tracks what you have not read. In this static rendering it shows every topic with activity in the last 45 days, which is the closest honest equivalent — we would rather explain the difference than pretend a static page knows your reading history.
414 topics · page 10 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What to include when your question involves a laboratory result
Asking directly, because I could not find a straight answer: What to include when your question involves a laboratory result Question in the title. Context below, and I have tried to include the things people…
|
+8 | 12 | 14k | 2d |
|
Follow-up: The retatrutide phase 2 obesity paper, read closely
The retatrutide phase 2 obesity paper, read closely — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+19 | 23 | 16k | 2d |
|
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people admit Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet ,…
|
+50 | 55 | 7.8k | 2d |
|
Micro-titration: a disputed topic, argued properly
Micro-titration: a disputed topic, argued properly Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been doing the…
|
+99 | 110 | 61k | 2d |
|
Alcohol: what is documented and what is folklore
Posting this under the heading it deserves: Alcohol: what is documented and what is folklore Everything below is what sits behind that. A question about technique rather than about dose. I have been doing the…
|
+120 | 134 | 11k | 2d |
|
What a certificate commits its issuer to — the long version
Asking directly, because I could not find a straight answer: What a certificate commits its issuer to — the long version A documentation question rather than an analytical one. I have a certificate in front…
|
+20 | 26 | 21k | 2d |
|
Impurity thresholds: where the common numbers come from
Impurity thresholds: where the common numbers come from — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in…
|
+11 | 15 | 825 | 2d |
|
Why chargeback is not the safety net people assume
Asking directly, because I could not find a straight answer: Why chargeback is not the safety net people assume A logistics question, since the answers here are usually better than anywhere else I have…
|
+22 | 26 | 2.5k | 2d |
|
Coming back to: Preparing for an appointment: one page, three questions
Preparing for an appointment: one page, three questions — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+51 | 56 | 1.4k | 2d |
|
Coming back to: Time to steady state after a dose increase
Time to steady state after a dose increase Writing it up because I had to work it out twice and would rather nobody else did. Posting the method first, because I know what the first three replies will…
|
+104 | 110 | 16k | 2d |
|
Coming back to: A community side-effect dataset, with its response rate and biases
Posting this under the heading it deserves: A community side-effect dataset, with its response rate and biases Everything below is what sits behind that. Working through the identity arithmetic and I would…
|
+96 | 101 | 33k | 2d |
|
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
|
+37 | 42 | 31k | 2d |
|
Stepping down deliberately, and how to do it without losing progress — what changed since
Posting this under the heading it deserves: Stepping down deliberately, and how to do it without losing progress — what changed since Everything below is what sits behind that. Practical question with the…
|
+94 | 99 | 29k | 2d |
|
Forced degradation studies: designing one that is informative
Posting this under the heading it deserves: Forced degradation studies: designing one that is informative Everything below is what sits behind that. Working through the identity arithmetic and I would like it…
|
+100 | 106 | 35k | 2d |
|
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
|
+74 | 80 | 17k | 2d |
|
Why catalogue breadth is not evidence of anything
Why catalogue breadth is not evidence of anything I have a specific reason for asking rather than idle curiosity, and the context is below. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a claim I…
|
2 | 38k | 2d | |
|
[2026 update] Why 99.2% and 97.8% on the same lot can both be correct
Why 99.2% and 97.8% on the same lot can both be correct — that is the question, and I have not found it answered plainly anywhere I have looked. I would like to understand what this number means before I…
|
+1 | 5 | 719 | 2d |
|
[2026 update] A report I filed that turned out to be wrong, and the correction
On the subject in the title: A report I filed that turned out to be wrong, and the correction Working notes rather than a conclusion. Structured report rather than an opinion, following the format the…
|
+15 | 19 | 18k | 2d |
|
Batch numbers that do not match the vial label
Batch numbers that do not match the vial label — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product…
|
+43 | 48 | 8.9k | 2d |
|
Coming back to: Payment method and the leverage it gives you, ranked
Payment method and the leverage it gives you, ranked — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the maintainers asked…
|
+21 | 26 | 43k | 2d |
|
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. General question, not a request for advice about my own care — I know the…
|
+51 | 55 | 9.2k | 2d |
|
How shortages have affected compounding permissions
How shortages have affected compounding permissions I have a specific reason for asking rather than idle curiosity, and the context is below. A coverage question with the paperwork detail included, since that…
|
+61 | 71 | 3.6k | 2d |
|
Ultrasound and skinfolds: operator dependence in practice
Ultrasound and skinfolds: operator dependence in practice — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that almost nobody…
|
+72 | 76 | 2.7k | 2d |
|
Revisiting: Protein density versus volume when you cannot eat much
Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+97 | 108 | 3.6k | 2d |
|
Programming during a large energy deficit
Programming during a large energy deficit — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that almost nobody writes about. I have…
|
+39 | 49 | 36k | 2d |
|
Review: an evidence digest and the citation check that delayed it
On the subject in the title: Review: an evidence digest and the citation check that delayed it Working notes rather than a conclusion. Nominating something for promotion into the documentation commons. The…
|
+13 | 17 | 15k | 2d |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of May 2026, in…
|
+10 | 14 | 27k | 2d |
|
Why the timeline is on the right and not the left — what changed since
Why the timeline is on the right and not the left — what changed since I have a specific reason for asking rather than idle curiosity, and the context is below. Nominating something for promotion into the…
|
+77 | 81 | 4k | 2d |
|
About the Adverse events category
Serious and unexpected events, how to document them, and where to report them officially. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+2 | 6 | 8.7k | 2d |
|
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction
The question in the title: Why a glucagon receptor agonist in a weight-loss compound is not a contradiction I will give what I have already checked below so nobody repeats it. Comparing LEADER ( N Engl J Med…
|
+43 | 47 | 19k | 2d |